Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank67
3Y CAGR-36.1%
5Y CAGR+67.9%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-36.1%/yr
Annual compound
5Y CAGR
+67.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
13.3x
Strong expansion
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2024$6.26M+281.0%
2023$1.64M-53.3%
2022$3.52M-85.4%
2021$24.03M+32.0%
2020$18.21M+3778.9%
2019$469353.00-62.6%
2018$1.25M-